InvestorsHub Logo
Followers 10
Posts 997
Boards Moderated 0
Alias Born 01/17/2005

Re: None

Friday, 04/22/2011 10:33:28 PM

Friday, April 22, 2011 10:33:28 PM

Post# of 18494
From RedChip Blog

Showcasing Hemopurifier for U.S. government officials: In January, Aethlon was invited by the Department of Health and Human Services (HHS) to present its Hemopurifier technology platform before multi-agency health officials. This presentation led to follow-on meetings and presentations, including a formal presentation to the Biomedical Advanced Research and Development Authority (BARDA) in February.

If recent data is any indication, Aethlon has ample opportunities to participate in government-funded biodefense programs. Freemind Group, a consultancy firm focused on governmental grant identification and application assistance for the biotechnology industry, recently reported that there has been a dramatic surge in biodefense and infectious disease funding opportunities from the U.S. government. They forecast that funding applications submitted during the months of May, June and July will result in cumulative awards of approximately $500 million. The Hemopurifier has potential applications across a wide range of infectious diseases, giving Aethlon a unique advantage over biotechnology companies whose technology platforms are designed to treat only a single disease
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News